Prime Medicine, Inc.
PRME · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$50,582 | -$52,591 | -$51,890 | -$42,276 |
| Dep. & Amort. | $1,881 | $1,453 | $1,536 | $1,717 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $6,325 | $5,681 | $0 |
| Change in WC | $609 | $548 | -$7,653 | $48,860 |
| Other Non-Cash | $13,053 | $2,853 | $3,469 | $7,944 |
| Operating Cash Flow | -$35,039 | -$41,412 | -$48,857 | $16,245 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$247 | -$1,572 | -$2,422 | -$1,791 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$134,306 | -$6,907 | -$48,320 | $16,868 |
| Inv. Sales/Matur. | $42,431 | $11,250 | $3,000 | $32,900 |
| Other Inv. Act. | $0 | $0 | $0 | $276 |
| Investing Cash Flow | -$92,122 | $2,771 | -$47,742 | $48,253 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $6,000 | $0 |
| Stock Issued | $138,753 | $197 | $0 | $1 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $6,000 | $0 | $0 | $0 |
| Financing Cash Flow | $144,753 | $197 | $6,000 | $1 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $17,592 | -$38,444 | -$90,599 | $64,499 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $53,804 | $105,939 | $196,538 | $117,977 |
| End Cash | $71,396 | $67,495 | $105,939 | $182,476 |
| Free Cash Flow | -$35,286 | -$42,984 | -$51,279 | $14,454 |